Literature DB >> 3023021

Calcium ion and cyclic adenosine 3',5'-monophosphate regulate proopiomelanocortin messenger ribonucleic acid levels in rat intermediate and anterior pituitary lobes.

J P Loeffler, N Kley, C W Pittius, V Höllt.   

Abstract

The role of the second messengers cAMP and Ca++ in the control of proopiomelanocortin (POMC) gene expression was investigated with the use of hybridization with cloned complementary DNA probes. The effects of cAMP-related drugs on POMC messenger RNA (mRNA) levels were assessed in primary cultures of intermediate (IL) and anterior rat pituitary cells maintained in serum-free medium. 8-Bromo-cAMP (1 mM), but not 8-bromo-cGMP (1 mM), induced a 2-fold increase in IL and anterior lobe cell after 2 days of treatment. A similar increase was obtained with the adenylate cyclase-activating drugs forskolin (1 microM) and cholera toxin (100 ng/ml) or the phosphodiesterase inhibitor RO 20-1724 (100 microM). At 48 h, all these treatments had increased beta-endorphin accumulation in the medium and transiently decreased the cellular beta-endorphin content in IL cells, suggesting a parallel effect of cAMP-related drugs on secretion and biosynthesis. Incubating the cells with the Ca++ channel antagonists D600 (50 microM), verapamil (50 microM), and the dihydropyridine nifedipine (0.1 microM) decreased basal POMC mRNA levels, whereas the dihydropyridine BAYK 8644 (0.1 microM), which activates the Ca++ channel, increased POMC mRNA levels after 2 days. In addition, nifedipine decreased the stimulatory effect of forskolin, whereas BAYK 8644 further stimulated the forskolin-increased POMC mRNA levels in IL cells. We conclude that both Ca++ and cAMP may regulate the gene expression of POMC.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023021     DOI: 10.1210/endo-119-6-2840

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.

Authors:  J P Behr; B Demeneix; J P Loeffler; J Perez-Mutul
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

2.  Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.

Authors:  T Suda; F Tozawa; I Dobashi; N Horiba; N Ohmori; M Yamakado; M Yamada; H Demura
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 3.  The role of intracellular messengers in adrenocorticotropin secretion in vitro.

Authors:  M S King; A J Baertschi
Journal:  Experientia       Date:  1990-01-15

4.  Transcriptional activation of the proopiomelanocortin gene by cyclic AMP-responsive element binding protein.

Authors:  A L Boutillier; C Gaiddon; D Lorang; J L Roberts; J P Loeffler
Journal:  Pituitary       Date:  1998-04       Impact factor: 4.107

5.  Dopamine D2 receptor stimulation alters G-protein expression in rat pituitary intermediate lobe melanotropes.

Authors:  S A Sands; D S Dickerson; S J Morris; B M Chronwall
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

6.  Ca2+ current expression in pituitary melanotrophs of neonatal rats and its regulation by D2 dopamine receptors.

Authors:  J C Gomora; G Avila; G Cota
Journal:  J Physiol       Date:  1996-05-01       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.